Are the principles of treatment of chronic osteitis applicable to the diabetic foot?;Les principes du traitement de l'ostéite chronique sont-ils applicables au pied diabétique?

Presse Medicale

Volumn 31, Issue 9, 2002, Pages 393-399

  Senneville, E ^a   Yazdanpanah, Y ^a   Cordonnier, M ^a   Cazaubiel, M ^a   Lepeut, M ^a   Baclet, V ^a   Beltrand, E ^a   Khazarjian, A ^a   Caillaux, M ^a   Dubreuil, L ^a   Mouton, Y ^a  

^a Serv Univ Reg Malad Infectieuses   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID TC 99M; GALLIUM CITRATE GA 67; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULESOMAB; SULESOMAB TC 99M;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE NECROSIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CHRONIC DISEASE; CLINICAL ARTICLE; DIABETIC FOOT; FEMALE; FOLLOW UP; HUMAN; MALE; ORTHOPEDIC SURGERY; OSTEITIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

AGED; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BIOPSY; CHRONIC DISEASE; DIABETIC FOOT; DRUG RESISTANCE, MULTIPLE; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; OSTEITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 17644440380     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Osteomyelitis of the foot in diabetic patients
2. Unsuspected osteomyelitis in diabetic foot ulcers: Diagnosing and monitoring by leukocyte scanning with indium ln111 oxyquinolone
3. Foot infections in diabetes: Evaluation and management
4. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
5. Quality of life following lower limb amputation for peripheral arterial disease
6. Use of ampiallin/sulbactam in the treatment of limb-threatening foot infections in diabetic patients
7. Antibiotic therapy of diabetic foot infections: A comparison of two parenteral-to-oral regimens
8. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
9. Management and outcome of severe diabetic foot infections
10. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet
11. Diabetic foot infections: Bacteriologic analysis
12. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycine and rifampin
13. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus
14. Out patient management of uncomplicated lower-extremity infections in diabetic patients
15. Lessons learned from animals models of osteomyelitis
16. Ofloxacin versus parenteral therapy for chronic osteomyelitis
17. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopaedic implants
18. Oral treatment of Staphylococcus spp. Infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin
19. Role of rifampin for treatment of orthopaedic implant-related staphylococcal infections
20. Tissue concentrations after a single-dose orally administered ofloxacin in patients with diabetic foot infections
21. The dysvascular foot a system for diagnosis and treatment
22. Outcome of diabetic foot infections treated conservatively
23. Conservative management of nosteomyelitis in the feet of diabetic patients
24. Osteomyelitis
25. Evidence-based antibiotic therapy of diabetic foot infections
26. Use of Sulesomab, a radiolabeled antibody fragment to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy
27. Drug interaction: Rifampin and glibenclamide
28. Interaction of rifampin and chlorpropamide
29. Adsorption and release of antibiotics from morselized cancellous bone: In vitro studies of 8 antibiotics
30. Osteomyelitis in the feet of diabetic patients